Ashva's iMAGIC imaging software:
This article was originally published in Clinica
Indian firm Ashva Technologies has received 510(k) clearance from the US FDA for its iMAGIC imaging software. The technology has been approved for a variety of tasks, including ultrasound image archiving, manipulation, creation of template-based reporting and burning the image onto media such as a CD or DVD. The Chennai-based firm claims to have installed over 500 iMAGIC units in Asia. The company also has US offices in Corinth, Texas, and a Malaysian facility in Selangor Darul Ehsan.
You may also be interested in...
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.
The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.